SCHEMBL272959

SCHEMBL272959

C1CC[C@H]2O[C@H]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3219 1.00
SCHEMBL14844281 1.00
SCHEMBL12203926 1.00
SCHEMBL12334971 1.00 ALDH1A1 (0.36)
SCHEMBL2183062 1.00
SCHEMBL7933931 1.00
SCHEMBL23934877 0.96 ALDH1A1 (0.33)
SCHEMBL51905 0.96 ALDH1A1 (0.33)
SCHEMBL7944366 0.96 ALDH1A1 (0.33)
Water SCHEMBL8733652 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6111125-A Preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl methyl ketone and derivatives and stereoisomers of this compound BASF AKTIENGESELLSCHAFT (DE) 2000-08-29 US claimed
EP-0671378-B1 Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers BASF AG (DE) 1997-01-29 EP claimed
US-20230192672-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL MYERS SQUIBB (US) 2023-06-22 US disclosed
EP-4146646-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 Bristol-Myers Squibb Company (US) 2023-03-15 EP disclosed
EP-2239291-B2 POLYETHER CARBONATE POLYOLS MADE VIA DOUBLE METAL CYANIDE (DMC) CATALYSIS COVESTRO LLC (US) 2022-03-09 EP disclosed
WO-2021226002-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL-MYERS SQUIBB COMPANY (US) 2021-11-11 WO disclosed
EP-3626795-A1 CURABLE COMPOSITION FOR ADHESIVE AGENT, ADHESIVE SHEET, CURED ARTICLE, LAMINATE, AND APPARATUS Daicel Corporation (JP) 2020-03-25 EP disclosed
EP-2763756-B1 BROMOFLUOROCARBON COMPOSITIONS AMERICAN PACIFIC CORP (US) 2019-06-12 EP disclosed
EP-2046861-B1 POLYETHER CARBONATE POLYOLS VIA CATALYSIS OF NON-CRYSTALLINE DOUBLE METAL CYANIDE (DMC) COVESTRO LLC (US) 2019-01-23 EP disclosed
WO-2017044572-A1 RING CONSTRAINED DIARYLAMINO SULFONAMIDES AS ANTI-CANCER AGENTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2017-03-16 WO disclosed
CN-105153133-A New compound for conversion of auricular fibrillation, preparation method, pharmaceutical composition and application ANHUI YIXINMING PHARMACEUTICAL TECHNOLOGY CO LTD 2015-12-16 CN disclosed
US-20070265472-A1 Asymmetric Reaction Catalyst and Method for Preparing Optically Active Compound Using the Same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-11-15 US disclosed
US-20070265472-A1 Asymmetric Reaction Catalyst and Method for Preparing Optically Active Compound Using the Same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-11-15 US disclosed
US-7192968-B2 Ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-20 US disclosed
US-20070004676-A1 Methods of using [3.2.0] heterocyclic compounds and analogs thereof TRIPHASE RESEARCH AND DEVELOPMENT I CORP. (CA) 2007-01-04 US disclosed
EP-1230207-B1 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2005-06-22 EP disclosed
US-6696597-B2 CROSS-METATHESIZING A TERMINAL OLEFIN AND INTERNAL OLEFIN IN PRESENCE OF CATALYST, TO FORM METATHESIS PRODUCT AND A SIDE PRODUCT; APPLYING CONDITIONS OF SUFFICIENTLY HIGH TEMPERATURE AND/OR LOW PRESSURE TO EVAPORTE SIDE PRODUCT TILLIECHEM, INC. 2004-02-24 US disclosed
US-20020022741-A1 Metathesis syntheses of pheromones or their components MATERIA, INC. 2002-02-21 US disclosed
US-6111125-A Preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl methyl ketone and derivatives and stereoisomers of this compound BASF AKTIENGESELLSCHAFT (DE) 2000-08-29 US disclosed
US-4500704-A POLYCARBONATE-ESTER COPOLYMER THE DOW CHEMICAL COMPANY (US) 1985-02-19 US disclosed